Creo Medical Group (CREO) Competitors GBX 19.53 -0.10 (-0.50%) (As of 11/1/2024 12:39 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades CREO vs. NIOX, EKF, NCYT, IUG, POLX, BELL, IHC, AVO, RUA, and MHCShould you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include NIOX Group (NIOX), EKF Diagnostics (EKF), Novacyt (NCYT), Intelligent Ultrasound Group (IUG), Polarean Imaging (POLX), Belluscura (BELL), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), and MyHealthChecked (MHC). These companies are all part of the "medical devices" industry. Creo Medical Group vs. NIOX Group EKF Diagnostics Novacyt Intelligent Ultrasound Group Polarean Imaging Belluscura Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences MyHealthChecked Creo Medical Group (LON:CREO) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability. Which has preferable valuation and earnings, CREO or NIOX? NIOX Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreo Medical Group£30.30M2.33-£22.40M-£0.06-325.45NIOX Group£39M6.87£11M£0.023,160.00 Does the MarketBeat Community favor CREO or NIOX? Creo Medical Group received 105 more outperform votes than NIOX Group when rated by MarketBeat users. However, 100.00% of users gave NIOX Group an outperform vote while only 67.52% of users gave Creo Medical Group an outperform vote. CompanyUnderperformOutperformCreo Medical GroupOutperform Votes10667.52% Underperform Votes5132.48% NIOX GroupOutperform Votes1100.00% Underperform VotesNo Votes Which has more volatility & risk, CREO or NIOX? Creo Medical Group has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Does the media refer more to CREO or NIOX? In the previous week, NIOX Group had 2 more articles in the media than Creo Medical Group. MarketBeat recorded 3 mentions for NIOX Group and 1 mentions for Creo Medical Group. Creo Medical Group's average media sentiment score of 0.67 beat NIOX Group's score of 0.25 indicating that Creo Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Creo Medical Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NIOX Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend CREO or NIOX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creo Medical Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ANIOX Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is CREO or NIOX more profitable? NIOX Group has a net margin of 30.00% compared to Creo Medical Group's net margin of -73.93%. NIOX Group's return on equity of 13.52% beat Creo Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets Creo Medical Group-73.93% -38.49% -20.09% NIOX Group 30.00%13.52%3.95% Do insiders & institutionals believe in CREO or NIOX? 56.1% of Creo Medical Group shares are held by institutional investors. Comparatively, 35.2% of NIOX Group shares are held by institutional investors. 22.4% of Creo Medical Group shares are held by company insiders. Comparatively, 46.7% of NIOX Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryNIOX Group beats Creo Medical Group on 12 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Creo Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CREO vs. The Competition Export to ExcelMetricCreo Medical GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£70.65M£1.99B£5.50B£1.54BDividend YieldN/A2.49%5.11%11.42%P/E Ratio-325.45207.40124.271,687.53Price / Sales2.33208.831,494.75223,574.70Price / Cash2.4316.0539.7835.45Price / Book1.503.244.772.85Net Income-£22.40M£70.94M£119.06M£143.44M7 Day Performance-2.36%-1.99%0.80%0.11%1 Month Performance-7.45%-3.95%5.65%-0.15%1 Year Performance-39.92%35.39%36.75%14.81% Creo Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CREOCreo Medical GroupN/AGBX 19.53-0.5%N/A-38.5%£70.65M£30.30M-325.45279Positive NewsNIOXNIOX GroupN/AGBX 62.19+0.6%N/A-2.1%£263.78M£39M3,109.6592Gap UpEKFEKF DiagnosticsN/AGBX 26.96+2.9%N/A-4.7%£122.32M£50.95M2,695.90356Gap UpHigh Trading VolumeNCYTNovacytN/AGBX 52.85-3.7%N/A+19.1%£37.33M£18.56M-101.63120Gap UpIUGIntelligent Ultrasound GroupN/AGBX 11-3.3%N/A+28.0%£35.97M£9.88M-1,100.0065Gap DownPOLXPolarean ImagingN/AGBX 1.42+1.7%N/A-80.6%£17.23M£1.87M-71.2028Gap UpBELLBelluscuraN/AGBX 10-2.4%N/A-64.7%£16.84M£1.80M-100.0024Gap DownIHCInspiration Healthcare GroupN/AGBX 15.50-6.1%N/A-55.0%£13.90M£34.30M-110.71224News CoverageAVOAdvanced OncotherapyN/AGBX 1.75-9.1%N/A+0.0%£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 12.13-3.0%N/A+2.6%£7.53M£2.19M-303.2048Gap UpMHCMyHealthCheckedN/AGBX 13.25-5.4%N/A+3.0%£6.89M£9.39M-662.5016Gap Down Related Companies and Tools Related Companies NIOX Group Competitors EKF Diagnostics Competitors Novacyt Competitors Intelligent Ultrasound Group Competitors Polarean Imaging Competitors Belluscura Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors MyHealthChecked Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:CREO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
